Over the past four years, early October has been a good entry point for biotech stocks. It could be that investors will now discover this trend and add to biotech positions earlier. Whether you are a trader or an investor, look for seasonality and momentum in the market. 2007 YTD has been a mixed year for biotechnology, with the broad-based iShares NASDAQ Biotechnology Index flat but the larger cap SPDR S&P Biotech up about 10% despite a weak June. The biotech sector peaked in early May as usual, prior to the ASCO meeting.
展开▼
